Our experimental evidence indicated that pharmacological inhibition of GCH1 using DAHP, in combination with the ferroptosis inducer RSL3, efficiently suppressed LLC tumor growth and prolonged the survival of tumor-bearing mice. The gene discussed is GCH1; the disease is neoplasm.